- Medifast Inc (NYSE:MED) has entered into an accelerated share repurchase agreement (ASR) with JPMorgan Chase, National Association.
- Under the agreement, Medifast will repurchase an aggregate of $100 million of its common stock.
- The buyback equates to about 600,000 shares at the closing price on May 31, 2022, representing 5% of its outstanding stock.
- The company intends to fund the ASR program using available cash on hand and borrowings under its existing credit facility.
- Medifast held $122.1 million in cash and equivalents as of March 31, 2022.
- Price Action: MED shares are trading higher by 5.16% at $175.36 on the last check Wednesday.
Nephros Q1 EPS $(0.20) Misses $(0.11) Estimate, Sales $2.20M Miss $3.08M Estimate
Nephros (NASDAQ:NEPH) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.11) by 81.82 percent. This is a 233.33 percent decrease over losses of $(0.06) per share from the
